Jessica Rapaport

Responsible for leading strategic account growth across a $6M specialty healthcare territory supporting reproductive endocrinology practices, academic fertility centers, and integrated healthcare systems.

• Develop and execute comprehensive strategic business plans to drive adoption of advanced genetic testing technologies and clinical fertility solutions.
• Partner with physicians, embryologists, laboratory leadership, nursing teams, and administrative stakeholders to influence treatment pathways and improve clinical outcomes.
• Deliver complex disease-state education related to genetic screening technologies, supporting clinical decision making and improving patient counseling confidence.
• Collaborate cross-functionally with clinical specialists, laboratory operations, reimbursement teams, medical education partners, and commercial leadership to optimize patient access and workflow integration.
• Build and maintain regional KOL relationships supporting peer-to-peer education and clinical program expansion.
• Successfully lead EMR integration, laboratory workflow implementation, and new clinical platform adoption across institutional accounts.
• Analyze market dynamics, payer trends, referral networks, and competitive intelligence to identify growth opportunities and adjust territory strategy.
• Utilize consultative, solution-based selling methodologies to align institutional goals with patient care objectives.

Performance Highlights
• 2024 – Achieved 130% of quota; Ranked #1 nationally; Summit Club Recipient
• Promoted to Executive Territory Account Manager and Certified Regional Trainer
• 2023 – Achieved 105.5% of quota
• 2022 – Promoted to Senior Territory Account Manager
• 2021 – Achieved 116% of quota
• 2019 – Achieved 103% of quota

Portfolio includes advanced genetic testing platforms, reproductive clinical technologies, laboratory solutions, donor services, and capital equipment.

• Managed capital equipment and disposable enteral nutrition portfolio across hospital systems and critical care environments.
• Navigated value analysis committees, supply chain leadership, and clinical stakeholders to implement new technologies.
• Led multidisciplinary product adoption initiatives involving physicians, nursing leadership, and purchasing executives.
• Closed $210K in capital equipment sales achieving 175% quota attainment.
• Generated $215K territory growth through strategic institutional account development.

• Promoted urology and pelvic health technologies across hospital and specialty practice settings.
• Partnered with physicians and surgical teams to improve procedural outcomes and drive adoption of advanced therapeutic technologies.

• Managed sharp safety portfolio across hospital and outpatient settings.
• Partnered with physicians, nursing leadership, and materials management to increase utilization and improve patient care outcomes.
• Achieved 104% quota attainment in 2011, 102% in 2010, and 101% in 2009.
• Recognized for driving market share growth through solution-focused consultative selling.

• Generated consistent new business through executive-level consultative sales presentations.
• Achieved 170% of quota in 2008 and 144% of quota in 2009.
• Earned multiple performance incentive awards and recognition programs.

• Delivered customized financial product solutions through relationship-driven consultative selling strategies.
• Consistently exceeded sales performance expectations.